B2Digital Reports 126% Q/Q Topline Growth, Projects Current Quarter Acceleration, Major Expansion in Fitness Facility Strategy

Tampa, FL – ( NewMediaWire ) – December 03, 2020 – B2Digital Incorporated (the “Company” or “B2Digital”) (OTCMKTS:BTDG), the premier development league for mixed martial arts (“MMA”), is excited to update shareholders on the Company’s outlook and the accelerating organic and strategic growth underway in its Gym segment, as well as its performance related to this strategy during the three months ended September 30, 2020, and its expectations for related performance during the current quarter ending December 31, 2020, and beyond.

Note that projections and guidance outlined below assume an absence of further regulatory lockdowns related to Covid-19 as well as the widespread distribution of a safe and effective vaccine during 2021.

“Based on the strategy we have in place – and the assumption that we don’t see major new pandemic-related shutdowns that impact the business – we are targeting $4-5 million on the topline over the rolling forward next twelve months,” commented Greg P. Bell, CEO of B2Digital. “This is based on the growth we are seeing now and the continued successful implementation of the company’s roll-up strategy in our Fitness Facility segment, which is the real breadwinner in our broad vision. We are already on pace to more than double the topline on a sequential quarterly basis into year-end.”

During the three months ended September 30, 2020, B2Digital saw a 76% jump in Gym revenues on a sequential quarterly basis. In addition, the Company increased overall revenues across segments totaling topline growth on a sequential quarterly basis during the quarter of 126%. Management also notes that, based on performance thus far and an assumption of no new pandemic-related shutdowns relevant to its current fitness facility operations, it projects a pace to achieve double the top line revenue in Q3 compared to Q2 of this year for the three months ending December 31, 2020.

In addition, the Company plans to continue its roll-up strategy in the fitness facility market over the coming twelve months. The Company’s objective is to acquire one to two new gym facilities every quarter with our goal to increase these acquisitions as the spread of Covid-19 decreases nationally. Thus far, each acquisition the Company makes in the fitness facility space is believed to represent at least $400K per year in rolling forward next twelve-month revenues based on past historical performance.

At this pace, given current metrics and assumptions, including no major return of mandated pandemic-related shutdowns relevant to its current fitness facilities, the Fitness Facility segment could achieve just shy of $4 million in revenues over the rolling forward next twelve months if the company’s acquisition objectives are executed as planned. Paired with a conservative assumption of $75K – $100K in monthly revenues from its live MMA events, encompassing 3 planned fights a month at current revenue achievement rates per fight, the Company believes it has the potential to achieve total revenues of at least $4 to $5 million over the rolling forward twelve months.

“Each acquisition we make in the Fitness Facility space is

Read more

How to Be Part of Men’s Health’s Next Major Virtual Health & Fitness Event

Men’s Health’s virtual event, MH Weekenders, is coming soon, and it’s going to be big.

We don’t want to give much away yet, but throughout the whole of January some of the world’s biggest and most respected athletes and personalities will be taking part. From Saturday night cook-alongs, to in-depth interviews and discussions as well group workouts and challenges to take part in, this festival has something for everyone.

We’re going big with this, and we want you to take part. This is your chance to reach out to our digital audience of over 5 million people.

This content is imported from YouTube. You may be able to find the same content in another format, or you may be able to find more information, at their web site.

What Are Men’s Health Virtual Events?

Unfortunately, getting together to get sweaty and debate the pressing issues in the world of health and fitness is not an option at the moment, which is why we’ve gone virtual.

Our events will take place over the last four weekends of January 2021 – Saturday 9th to Sunday January 31st – with each day comprising of four structured events that will be hosted on the Men’s Health YouTube channel. These videos will also be featured in digital articles and posted across menshealth.com/uk, Twitter, Facebook and Instagram.

The line-up will be announced in the coming weeks, so keep an eye out.

How You Can Get Involved

Of course, the line-up is not all we’re shouting about. We recognise that with such an event, this is a great opportunity for brands to showcase their products and services to our audience. So, we’ve devised a few new ways for you to reach them. Virtually, of course.

Register your brand

MH Weekenders Marketplace

The MH Weekenders Marketplace will offer businesses the chance to exhibit with us. On the final weekend of January, event attendees will be able to attend the online marketplace where they’ll be able to shop and receive discounts to their favourite health brands.

MH Weekenders E-Zine

As an event bonus, our registered attendees will receive our free e-zine ­– a digital event guide and marketplace electronic magazine, which will feature a selection of our favourite wellness brands.

If you’re a brand looking to get involved, sign up via the registration from below.

Register your brand


Sign up to the Men’s Health newsletter and kickstart your home body plan. Make positive steps to become healthier and mentally strong with all the best fitness, muscle-building and nutrition advice delivered to your inbox.

SIGN UP

For effective home workouts, uplifting stories, easy recipes and advice you can trust, subscribe to Men’s Health UK.

SUBSCRIBE

This content is created and maintained by a third party, and imported onto this page to help users provide their email addresses. You may be able to find more information about this and similar content at piano.io

Source Article

Read more

Traditional Chinese Medicine Market is Driven by Rise in Popularity among Major Population from all Across the World

Global Traditional Chinese Medicine Market: Snapshot

In recent period, the major population from all across the world is inclined toward the use of traditional Chinese medicines. As a result, the traditional Chinese medicine market is experiencing notable expansion opportunities.

The traditional Chinese medicines are found to be helpful in protecting an individual’s cognitive health, maintaining their strength as well as flexibility. As a result, they are gaining popularity among major population from all across the world. This factor will drive the growth of the traditional Chinese medicine market in the years to come.

Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=78855

TMR’s upcoming research report on the traditional Chinese medicine market focuses on providing in-depth study of diverse important factors shaping the future of this market. It includes study of challenges, drivers, restraints, and opportunities in the market for traditional Chinese medicine. Apart from this, the report delivers dependable data on shares, volume, and revenues of the market for traditional Chinese medicine. Thus, the report is a valuable handbook for all entities working in the traditional Chinese medicine market during the forecast period of 2020 to 2030.

The global traditional Chinese medicine market is segmented on the basis of various key factors such as product type, application, and region. Based on product type, the market for traditional Chinese medicine is bifurcated into Chinese herbal medicine and acupuncture and Tai Chi.

Global Traditional Chinese Medicine Market: Growth Dynamics

The traditional Chinese medicine market is witnessing prominent growth avenues on the back of increased acceptance from various developed and developing countries. The world is witnessing noteworthy growth in the number of older populace. This factor is pushing the market growth. This aside, the improved disposable income of major people in the world is expected to drive the growth of the traditional Chinese medicine market.

Growing urbanization, technological advancements in healthcare sector, and presence of favorable health insurance policies are some of the key factors stimulating the growth opportunities in the traditional Chinese medicine market. This aside, presence of favorable government policies will support the growth of the market for traditional Chinese medicine in the years ahead.

Request for Analysis of COVID-19 Impact on Traditional Chinese Medicine Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=78855

Global Traditional Chinese Medicine Market: Notable Development and Competitive Analysis

The traditional Chinese medicine market witnesses presence of gamut of players. As a result, the competitive landscape of the market for traditional Chinese medicine is highly intense. To sustain in this scenario, gamut of vendors working in this market are executing diverse strategies. Many players are growing their expenditure on research and development activities. This aside, many vendors are engaged in the launch of new products. All these activities connote that the traditional Chinese medicine market will experience remarkable growth in the upcoming years.

The list of key players in the traditional Chinese medicine market includes:

  • Apicare Pain Clinic
  • Tongrentang Hospital
  • Beijing Chinese Medicine Hospital
  • Dongzhimen Hospital
  • Beijing Hua Kang Hospital
  • Mayo Clinic
  • YinOvaCenter and WOTCM

Pre Book Traditional Chinese Medicine Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=78855&ltype=S

Read more

Precision Medicine Group Secures Major Investment from Blackstone

NEW YORK & BETHESDA, Md.–(BUSINESS WIRE)–Nov 20, 2020–

Precision Medicine Group (PMG) and Blackstone (NYSE: BX) today announced that PMG, a leading next-generation provider of drug development and commercialization services, has completed a major investment and recapitalization led by funds managed by Blackstone (“Blackstone”). The investment includes significant participation from Precision’s co-founders, Ethan Leder and Mark Clein, as well as current shareholders Berkshire Partners, TPG Growth, Oak HC/FT, and Vida Ventures.

Bethesda, Maryland-based PMG is a leading provider of mission-critical services to help biopharmaceutical companies conduct clinical trials and bring novel therapies to market by integrating deep therapeutic knowledge, data and analytics, and human expertise. With precision medicine as its foundation, PMG’s specialized capabilities enable the development and delivery of more targeted treatments for patients, addressing the next wave of innovation in global health advancement, expanded access, and outcomes improvement.

This new round of investment will fuel the expansion of PMG’s global footprint and technical capabilities to help accelerate the development, approval, and commercial reach of breakthrough treatments from life science innovators. Blackstone’s deep understanding of the drug development process and extensive operating resources will help deliver significant value to the partnership.

Mark Clein, PMG CEO, said: “We are thrilled to have Blackstone join us for this next phase of growth. Their serious commitment to the life sciences and global scope and scale make them an ideal partner to support our vision of success and expanded capabilities for the next generation of bio-pharma innovators.”

Julia Kahr, a Senior Managing Director at Blackstone, said: “PMG has built a compelling set of services that address the most important challenges facing biopharmaceutical and diagnostic companies. We are eager to back Mark and Ethan and the highly talented employees around the world to support their deep and ongoing commitment to PMG’s clients and look forward to pursuing the immense opportunity ahead by leveraging new technologies, expertise, and scale. We are also delighted to be joining Berkshire, TPG Growth, Oak HC/FT, and Vida to help accelerate this success.”

Anushka Sunder, Managing Director at Blackstone, added: “We have high conviction in the unprecedented wave of innovation PMG’s clients are driving in personalized medicines and novel drug mechanisms, especially in oncology and rare disease. PMG integrates deep science, extensive biomarker and genetic data, evidence of economic value, and market access insights to improve the speed, cost, and success rates of bringing life-changing therapies to patients. We are excited to support the continued expansion of PMG’s platform and broad therapeutic reach.”

Goldman Sachs & Co. LLC acted as lead financial advisor to PMG. Jefferies LLC and Perella Weinberg Partners also acted as financial advisors to PMG and Debevoise & Plimpton LLP acted as legal advisor to PMG. Morgan Stanley & Co. LLC, BofA Securities, and Barclays acted as financial advisors and Sullivan & Cromwell LLP acted as legal advisor to Blackstone. Terms of the transaction were not disclosed.

About Precision Medicine Group:

Formed in 2012, Precision Medicine Group is a specialized services company supporting next generation approaches to

Read more

Unlike previous lethal viruses, this one will define a major election

From a single case in Snohomish County, Wash., on Jan. 21, the coronavirus has mushroomed in less than 10 months to a widening scourge currently infecting nearly 100,000 Americans a day. As Election Day voters prepared to cast their ballots Tuesday, the medical examiner in El Paso was adding a fourth refrigerated “mobile morgue,” and hospitals in northwest Wisconsin were canceling elective procedures to save beds for patients with covid-19, the disease caused by the virus.

Two-thirds of the public now personally know one of the 9.25 million people who have tested positive for the virus — a new high — polls show. And even more think the worst of the pandemic is yet to come.

“We’ve never had an Election Day in the fog of a pandemic like this,” said Howard Markel, a medical historian at the University of Michigan. “It will, perhaps, be called the pandemic election.”

How those factors affect turnout and results won’t be known until evening, and perhaps not for days or weeks to come. But it is already clear that Tuesday will mark a singular modern-day confluence of a U.S. public health crisis and the election of a president.

“To my knowledge, it’s unprecedented,” said Harvey V. Fineberg, president of the Gordon and Betty Moore Foundation and co-author of “The Epidemic That Never Was,” an analysis of the federal swine flu immunization program in 1976. “Which means one has no basis for comparison.”

In the 1920 presidential election, voters faced a waning threat from the pandemic flu, there was no flu vaccine, and public health was seen as a local issue that did not merit intervention by the president. The Centers for Disease Control and Prevention did not exist. Even during the 1918 off-year election, the pathogen that would eventually kill 675,000 Americans was not a major subject of debate, Markel said.

Periodic flu outbreaks during ensuing decades did not move the political needle much either.

The worst polio outbreaks, in the 1940s and early 1950s, tended to wane as the weather cooled, and the virus was eventually quelled by successful testing of a vaccine in 1955.

Even HIV, which drove activists into the streets, had little impact at election time, at least during the epidemic’s first decade. President Ronald Reagan, who took office in 1981, the year the virus was first recognized, famously would not utter the word “AIDS” until 1987.

Tuesday will be much different.

“I have no idea what it will do in terms of turnout,” said Tom Inglesby, director of the Center for Health Security at the Bloomberg School of Public Health.

“What I’m hoping is that people are not afraid to vote in person if they haven’t voted yet,” he added. “Because I do think it’s possible to vote in a way where you can control your risk so that it wouldn’t be too different from going to the grocery store or going to the pharmacy.”

That includes voting in the late morning or early afternoon, when crowds are

Read more

Canada says stronger response needed to fight coronavirus, PM hopes to avoid major shutdown

OTTAWA (Reuters) – Canadians need to do more to tackle a second wave of the coronavirus by slashing the number of personal contacts they have with others, health authorities said on Friday.

FILE PHOTO: People walk in the Eaton Centre shopping mall, as the provincial phase 2 of reopening from the coronavirus disease (COVID-19) restrictions begins in Toronto, Ontario, Canada June 24, 2020. REUTERS/Carlos Osorio/File Photo

Prime Minister Justin Trudeau said more targeted measures could help avert another major national shutdown of the kind that hammered the economy earlier in the year.

Released modeling updates show the cumulative death toll in the country could range between 10,285 and 10,400 by Nov 8. Cumulative cases could be between 251,800 and 262,200 by the same date.

“(The) long-range forecast indicates that a stronger response is needed now to slow the spread of COVID-19,” chief public health officer Theresa Tam told a briefing.

“If we decrease our current rate of contacts by 25% the epidemic is forecast to come under control in most locations,” she said.

Canada has recorded 10,074 deaths and 228,542 cases so far and is breaking daily records for the number of new cases.

Suncor Energy SU.TO, Canada’s second-biggest oil producer, confirmed 19 infections among workers at its Firebag oil sands site in Alberta, dating back to Oct. 18. All of those affected are in isolation at home or other locations, spokeswoman Erin Rees said.

Suncor shut down part of the site where 17 of the employees worked, but the outbreak has not affected oil production, she said.

Some provinces are reintroducing bans on indoor dining and limiting the size of gatherings.

Manitoba, which has the highest rate of active cases per capita among provinces, said it would tighten restrictions starting on Monday. In Winnipeg, where most cases are located, all restaurants and bars will close to in-person dining.

Trudeau said authorities know more now about the pandemic than they did six months ago.

“There are things we can do to help to control the pandemic, the second wave, without – we hope – having to impose a nationwide shutdown,” he told the briefing.

Additional reporting by Rod Nickel in Winnipeg and Moira Warburton in Toronto; Editing by Kirsten Donovan, Aurora Ellis and Sonya Hepinstall

Source Article

Read more

Work by Minnesota researchers reveals deadly combo: COVID and major heart attacks

Complications from COVID-19 can make the most dangerous kinds of heart attacks even more deadly, according to a new study.

The finding has special implications for African American and Hispanic residents, as well as diabetics, since those three groups are at greater risk of having severe heart attacks and contracting COVID-19.

In a first-of-its-kind effort, a group of North American heart hospitals examined nearly 600 patients and found a surprisingly high death rate among COVID-19 patients with the most severe heart attacks, caused by complete blockage of an artery supplying oxygen to the heart muscle.

“These patients are at very high risk,” said interventional cardiologist Dr. Santiago Garcia, primary investigator at the Minneapolis Heart Institute Foundation, where the data are being analyzed. “Mortality for heart attack patients … should be in single digits. We’re seeing mortality here that is 32%.”

The findings, announced at a medical conference this month, were the public’s first glimpse of results from the ongoing project known as NACMI, an international consortium compiling data from COVID-19 patients who have a so-called “STEMI” heart attack involving a completely blocked blood vessel.

The study examined 594 STEMI patients treated at 64 hospitals during the pandemic in Canada and the U.S. through Oct. 4 and found those with confirmed cases of COVID died in the hospital at almost triple the rate as those who tested negative for the viral illness.

About 20% of all heart attacks are thought to be STEMI.

The study also documented an increased risk of in-hospital strokes among COVID-positive heart-attack patients.

The NACMI findings aren’t published in a journal yet, but the initial data were presented Oct. 14 at the annual Transcatheter Cardiovascular Therapeutics conference.

Scientists widely believe COVID makes heart attacks and strokes more likely, and more dangerous, by causing changes in the heart, lungs and blood. The NACMI research can’t prove COVID triggers heart attacks and strokes — only that mortality rose when both were present.

But doctors say the correlation is noteworthy.

“Those are stunning numbers,” said Dr. Mladen Vido­vich, an interventional cardiologist and associate journal editor in Chicago who was not involved in the research. He said the death rate in the COVID group was similar to what was seen among heart-attack patients 50 years ago.

The risks are especially significant for African American and Hispanic patients, who tested positive for COVID more often than white and Asian patients in the first release of NACMI data. Organizers will be adding patients in Mexico and South America and tracking long-term outcomes.

Cardiologists say the early results underscore the longstanding recommendation that people feeling heart-attack signs should go to the hospital — even with hospitalizations for COVID-19 on the rise.

In Minnesota, 500 people have been admitted to the hospital for COVID-19 in the past week, including 106 cases sent to intensive care, the Minnesota Department of Health reported.

On Sunday, the Health Department added 1,684 new cases to the state’s tally, which now stands at 133,802. The deaths of 2,335 Minnesotans have

Read more

Tuberculosis is a major worldwide threat and the pandemic could make it worse, WHO says

In a new report, WHO provides a global update on the state of TB and the fight against the disease, which is both preventable and curable.

The report paints a dire picture of a disease that remains a public health crisis. Just eight countries — India, Indonesia, China, the Philippines, Pakistan, Nigeria, Bangladesh and South Africa — account for two-thirds of the world’s TB cases. And because many carriers of the disease are not yet ill, it can go untreated until it’s too late.

Tuberculosis incidences are falling, the agency says — between 2015 and 2019, cases were reduced by about 9 percent. But that still falls short of WHO’s targets.

The coronavirus pandemic is expected to make things worse.

Large drops occurred in TB diagnoses between January and June. Due to the economic effects of the pandemic, WHO models predict that cases could annually increase by more than 1 million in the next five years if resources continue to be diverted to covid-19, the disease caused by the coronavirus.

The stark report has positive news however. Funding for TB prevention, diagnosis and treatment has doubled since 2006, and seven high-burden countries reached their death reduction milestone. And people living with HIV are more likely than ever to be given preventive treatment for tuberculosis, which is the leading killer of people with HIV worldwide.

The report is available online or as an interactive app. To download, visit bit.ly/TBreportapp.

Source Article

Read more

US faces major hurdles for COVID-19 vaccine distribution: Vaccine advisory committee

Any coronavirus vaccine that could be authorized for emergency use by the U.S. Food and Drug Administration (FDA) faces several additional hurdles after completing the final stage of clinical trials.

That was the theme of key issues addressed today by the FDA’s vaccine advisory committee — which includes a group of health and science experts who advise the regulatory agency on the best way to approach the path forward for a COVID-19 vaccine.

Among the more immediate hurdles, the path to receive an emergency use authorization remains somewhat murky for the pharmaceutical industry, as the agency has not nailed down specifics for things such as labeling and what qualifies as sufficient monitoring of individuals who have enrolled in clinical trials.

Trial kits for Pfizer coronavirus disease (COVID-19) vaccination study are seen at the Research Centers of America, in Hollywood, Florida, U.S., September 24, 2020. REUTERS/Marco Bello
Trial kits for Pfizer coronavirus disease (COVID-19) vaccination study are seen at the Research Centers of America, in Hollywood, Florida, U.S., September 24, 2020. REUTERS/Marco Bello

In separate letters to the committee, Pfizer (PFE), Johnson & Johnson’s (JNJ) Janssen and trade group BIO all asked for more clarity on the follow-up period for participants following the final dose of the vaccine.

J&J wrote that the current guidelines ask for 50% of the trial population to be monitored for two months following the final dosing. With J&J enrolling 60,000 participants, and other competitors only enrolling 30,000, that provides an uneven playing field.

“Specifying a minimum required follow-up in terms of subjects and months … would ensure consistency across all studies,” the company wrote.

Another concern is what happens to trial participants — especially in a placebo group — after an emergency use authorization is awarded. The FDA’s guidelines require that the placebo group is maintained so that collection of data for safety and efficacy continues on through until the vaccine can be fully approved — especially since the vaccine would still be considered “investigational” at the point.

Pfizer had said it anticipates offering the vaccine to the placebo participants once it receives an emergency use authorization (EUA) — which is an ethical obligation, according to BIO.

“Additional discussion is needed to determine how placebo-controlled trials can be maintained after an EUA is granted. As an industry, we have an ethical obligation to make our trial participants aware that a vaccine may be available,” wrote BIO’s senior director of infectious disease policy Gregory Frank.

FDA’s deputy director of vaccines, Doran Fink, said the trial has to remain blinded because that isn’t a step that can be walked back and it could jeopardize the integrity of the massive trials.

When asked what can be done to ensure that participants don’t simply then drop out of the trial or choose to take the vaccine, Fink said the FDA had no idea and is asking the companies to figure it out and describe their plan in any emergency use authorization filings.

Distribution and administration

What happens after an EUA is also of concern, as the distribution process for two frontrunners — Moderna (MRNA) and Pfizer — requires extra cold temperatures. While Moderna has

Read more

HSG Foresees Major Potential Financial Impact on Employed Physician Networks and Medical Groups from 2021 Proposed Medicare Physician Fee Schedule

Healthcare Consultants Urge Hospitals and Health Systems to Start Planning for Impact on Physician Compensation and Medicare Payments for Professional Services.

Neal D. Barker, Partner at HSG, a national healthcare consulting firm is the author of "Changes to the 2021 Medicare Physician Fee Schedule Could Have Major Impact on Physician Compensation." The article is available for download at the website, hsgadvisors.com.
Neal D. Barker, Partner at HSG, a national healthcare consulting firm is the author of “Changes to the 2021 Medicare Physician Fee Schedule Could Have Major Impact on Physician Compensation.” The article is available for download at the website, hsgadvisors.com.
Neal D. Barker, Partner at HSG, a national healthcare consulting firm is the author of “Changes to the 2021 Medicare Physician Fee Schedule Could Have Major Impact on Physician Compensation.” The article is available for download at the website, hsgadvisors.com.

Louisville, KY, Oct. 21, 2020 (GLOBE NEWSWIRE) — HSG, a national healthcare consulting firm, has published a detailed evaluation of the Centers for Medicare & Medicaid Services (CMS) 2021 Medicare Physician Fee Schedule (MPFS) Proposed Rule, which is scheduled to take effect on January 1, 2021, if approved in the Final Rule. The advisors at HSG believe the proposed changes may have a significant potential impact on physician compensation and urge healthcare executives to start planning for these proposed changes. The agency’s Fee Schedule changes cover everything from Work Relative Value Unit (wRVU) values for specific Current Procedural Terminology (CPT) codes to changes in the scope of practice policies for Advanced Practice Providers (APPs) and changes related to CMS’s quality payment program.

With more than a 10% decrease in the MPFS conversion factor, services that do not have any change in Relative Value Unit values will see a decrease in Medicare payment at the projected rate of more than 10%. The decreased reimbursement will not be fully offset by any reimbursement increases realized through the Quality Payment Program paths. Changes related to outpatient and office evaluation and management (E&M) service code determinations and requirements, along with permanent and temporary additions to telehealth codes, will add to compensation complications. The redefined E&M code selection criteria will now be driven by medical decision making (MDM) or time spent alone – with no direct contribution by history and/or exam elements.

“Assuming these changes are included when the Final Rule is published in early December, many industry organizations, consultancies, and provider advocacy groups are projecting significant increases in provider productivity-based compensation if the providers’ E&M profile remains unchanged,” explained Neal Barker, Partner at HSG. “Ultimately, hospitals and health systems may face a situation in which payments from Medicare will decrease while their physician compensation requirements will significantly increase based on the widespread use of wRVU-based compensation models for employed physicians and APPs.”

As the roll-out date for the new Fee Schedule grows closer, HSG is working with healthcare systems to help them gain an understanding of the potential impact on the network.  Then HSG works with the organization to build a model to address changes to wRVU targets and bonus conversion factors that yield productive compensation levels that are financially sustainable and uphold fair market value and commercial reasonableness. Coincident with the compensation impact review, HSG conducts a series of provider

Read more